Administration of an mTOR inhibitor to treat patients with cancer

Details for Australian Patent Application No. 2006315512 (hide)

International Classifications

Event Publications

5 June 2008 PCT application entered the National Phase

PCT publication WO2007/059106 Priority application(s): WO2007/059106

3 July 2008 Amendment Made

The nature of the amendment is: Amend the invention title to read: Administration of an mTOR inhibitor to treat patients with cancer

11 June 2009 Assignment before Grant

Ariad Gene Therapeutics, Inc. The application has been assigned to ARIAD Pharmaceuticals, Inc.

1 November 2012 Application Accepted

Published as AU-B-2006315512

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.